Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy

• Main Authors: Azin Dehghanimahmoudabadi, MD (Author), Nika Kianfar, MD, MPH (Author), Marwa Akhdar, MD (Author), Shayan Dasdar, MD, MPH (Author), Kamran Balighi, MD (Author), Hamidreza Mahmoudi, MD (Author), Maryam Daneshpazhooh, MD (Author)
• Format: Book
• Published: Wolters Kluwer, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: . Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. Objectives: . To report pregnancy outcomes of patients with pemphigus who were treated with RTX before or during pregnancy. Methods: . We ident...